Perivascular CD73+ cells attenuate inflammation and interstitial fibrosis in the kidney microenvironment.

Progressive tubulointerstitial fibrosis may occur after acute kidney injury due to persistent inflammation. Purinergic signaling by 5'-ectonucleotidase, CD73, an enzyme that converts AMP to adenosine on the extracellular surface, can suppress inflammation. The role of CD73 in progressive kidney fibrosis has not been elucidated. We evaluated the effect of deletion of CD73 from kidney perivascular cells (including pericytes and/or fibroblasts of the Foxd1+ lineage) on fibrosis. Perivascular cell expression of CD73 was necessary to suppress inflammation and prevent kidney fibrosis in Foxd1CreCD73fl/fl mice evaluated 14 days after unilateral IRI or folic acid treatment (250 mg/kg). Kidneys of Foxd1CreCD73fl/fl mice had greater collagen deposition, expression of proinflammatory markers (including various macrophage markers), and PDGFRβ immunoreactivity than CD73fl/fl mice. Kidney dysfunction and fibrosis was rescued by administration of soluble CD73 or by macrophage deletion. Isolated CD73-/- kidney pericytes displayed an activated phenotype (increased proliferation and αSMA mRNA expression) compared to WT controls. In conclusion, CD73 in perivascular cells may act to suppress myofibroblast transformation and influence macrophages to promote a wound healing response. These results suggest that the purinergic signaling pathway in the kidney interstitial microenvironment orchestrates perivascular cells and macrophages to suppress inflammation and prevent progressive fibrosis.

[1]  Liping Huang,et al.  Epithelial and Endothelial Pannexin1 Channels Mediate AKI. , 2018, Journal of the American Society of Nephrology : JASN.

[2]  B. Humphreys.  Mechanisms of Renal Fibrosis. , 2018, Annual review of physiology.

[3]  Liping Huang,et al.  Dynamin-Related Protein 1 Deficiency Promotes Recovery from AKI. , 2017, Journal of the American Society of Nephrology : JASN.

[4]  Liping Huang,et al.  Sphingosine Kinase 2 Deficiency Attenuates Kidney Fibrosis via IFN-γ. , 2017, Journal of the American Society of Nephrology : JASN.

[5]  Liping Huang,et al.  Proximal Tubule CD73 Is Critical in Renal Ischemia-Reperfusion Injury Protection. , 2017, Journal of the American Society of Nephrology : JASN.

[6]  R. Kramann,et al.  Gli1+ Pericyte Loss Induces Capillary Rarefaction and Proximal Tubular Injury. , 2017, Journal of the American Society of Nephrology : JASN.

[7]  L. Cantley,et al.  Macrophages in Renal Injury and Repair. , 2017, Annual review of physiology.

[8]  R. Unwin,et al.  Purinergic signaling in kidney disease. , 2017, Kidney international.

[9]  J. Lambris,et al.  Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis. , 2017, American journal of physiology. Renal physiology.

[10]  Liping Huang,et al.  Vagus nerve stimulation mediates protection from kidney ischemia-reperfusion injury through α7nAChR+ splenocytes. , 2016, The Journal of clinical investigation.

[11]  A. Fogo,et al.  Distinct subpopulations of FOXD1 stroma-derived cells regulate renal erythropoietin. , 2016, The Journal of clinical investigation.

[12]  T. Wynn,et al.  Macrophages in Tissue Repair, Regeneration, and Fibrosis. , 2016, Immunity.

[13]  Liping Huang,et al.  Endothelial Sphingosine 1‑Phosphate Receptor‑1 Mediates Protection and Recovery from Acute Kidney Injury. , 2016, Journal of the American Society of Nephrology : JASN.

[14]  J. Kellum,et al.  Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments. , 2016, Journal of the American Society of Nephrology : JASN.

[15]  H. Clevers,et al.  Reparative inflammation takes charge of tissue regeneration , 2016, Nature.

[16]  M. Idzko,et al.  Purinergic signaling in scarring , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  M. Okusa,et al.  Driving change: kidney proximal tubule CSF-1 polarizes macrophages. , 2015, Kidney international.

[18]  Emily K. Kelly,et al.  Proximal tubule-derived Colony Stimulating Factor-1 mediates polarization of renal macrophages and dendritic cells, and recovery in acute kidney injury , 2015, Kidney international.

[19]  J. Bonventre,et al.  Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD , 2015, Nature Reviews Nephrology.

[20]  D. Harris,et al.  Macrophages in kidney injury, inflammation, and fibrosis. , 2015, Physiology.

[21]  J. Weinberg,et al.  Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression. , 2015, Journal of the American Society of Nephrology : JASN.

[22]  H. Lee,et al.  Adenosine receptors and renal ischaemia reperfusion injury , 2015, Acta physiologica.

[23]  Tetsuhiro Tanaka,et al.  Hypoxia as a key player in the AKI-to-CKD transition. , 2014, American journal of physiology. Renal physiology.

[24]  J. Duffield,et al.  The FOXD1 lineage of kidney perivascular cells and myofibroblasts: functions and responses to injury , 2014, Kidney international supplements.

[25]  R. Kramann,et al.  Kidney pericytes: roles in regeneration and fibrosis. , 2014, Seminars in nephrology.

[26]  J. Duffield.  Cellular and molecular mechanisms in kidney fibrosis. , 2014, The Journal of clinical investigation.

[27]  M. Idzko,et al.  Nucleotide signalling during inflammation , 2014, Nature.

[28]  R. Kalluri,et al.  Origin and function of myofibroblasts in kidney fibrosis , 2013, Nature Medicine.

[29]  Bettina Zelger,et al.  The immunology of fibrosis. , 2013, Annual review of immunology.

[30]  Jianchun Chen,et al.  CSF-1 signaling mediates recovery from acute kidney injury. , 2012, The Journal of clinical investigation.

[31]  D. Parekh,et al.  Kidney pericytes: a novel therapeutic target in interstitial fibrosis. , 2012, Histology and histopathology.

[32]  T. Wynn,et al.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.

[33]  J. Duffield,et al.  Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. , 2011, Kidney international.

[34]  J. Bonventre,et al.  Cellular pathophysiology of ischemic acute kidney injury. , 2011, The Journal of clinical investigation.

[35]  J. Duffield,et al.  Mechanisms of fibrosis: the role of the pericyte , 2011, Current opinion in nephrology and hypertension.

[36]  B. Molitoris,et al.  Pathophysiology of ischemic acute kidney injury , 2011, Nature Reviews Nephrology.

[37]  W. Junger,et al.  Immune cell regulation by autocrine purinergic signalling , 2011, Nature Reviews Immunology.

[38]  Sik Lee,et al.  Distinct macrophage phenotypes contribute to kidney injury and repair. , 2011, Journal of the American Society of Nephrology : JASN.

[39]  Hui Geng,et al.  Acute kidney injury: a springboard for progression in chronic kidney disease. , 2010, American journal of physiology. Renal physiology.

[40]  R. Kalluri,et al.  Methylation determines fibroblast activation and fibrogenesis in the kidney , 2010, Nature Medicine.

[41]  T. Wynn.  Fibrosis under arrest , 2010, Nature Medicine.

[42]  Li Yang,et al.  Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury , 2010, Nature Medicine.

[43]  C. Schwentner,et al.  The immunology of fibrosis: innate and adaptive responses. , 2010, Trends in immunology.

[44]  V. Haase.  Pathophysiological Consequences of HIF Activation , 2009, Annals of the New York Academy of Sciences.

[45]  Liping Huang,et al.  The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. , 2008, Kidney international.

[46]  M. Le Hir,et al.  The renal cortical interstitium: morphological and functional aspects , 2008, Histochemistry and Cell Biology.

[47]  Dan Yang,et al.  The Reno-Vascular A2B Adenosine Receptor Protects the Kidney from Ischemia , 2008, PLoS medicine.

[48]  D. Basile.  The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. , 2007, Kidney international.

[49]  H. Osswald,et al.  Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia. , 2007, Journal of the American Society of Nephrology : JASN.

[50]  V. Vallon,et al.  Ecto-5'-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo. , 2006, American journal of physiology. Renal physiology.

[51]  G. Weisman,et al.  P2 receptors: intracellular signaling , 2006, Pflügers Archiv.

[52]  Liping Huang,et al.  Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. , 2005, American journal of physiology. Renal physiology.

[53]  S. Nasr,et al.  A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion. , 2004, American journal of physiology. Renal physiology.

[54]  Liping Huang,et al.  Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. , 2003, The Journal of clinical investigation.

[55]  M. Burdick,et al.  IL-12 attenuates bleomycin-induced pulmonary fibrosis. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[56]  V. Lefebvre,et al.  Potent Inhibition of the Master Chondrogenic FactorSox9 Gene by Interleukin-1 and Tumor Necrosis Factor-α* , 2000, The Journal of Biological Chemistry.

[57]  G. Gabbiani,et al.  Interferon-γ inhibits experimental renal fibrosis , 1999 .

[58]  M. Le Hir,et al.  Distribution and regulation of renal ecto-5'-nucleotidase: implications for physiological functions of adenosine. , 1993, The American journal of physiology.

[59]  J. Jackson,et al.  Inhibition of bovine retinal microvascular pericyte proliferation in vitro by adenosine. , 1992, The American journal of physiology.

[60]  R. Meagher,et al.  Modulation of erythropoietin production by adenosine. , 1988, The Journal of laboratory and clinical medicine.

[61]  W. Spielman,et al.  Renal handling and production of plasma and urinary adenosine. , 1985, The American journal of physiology.

[62]  U. Dubach,et al.  Sodium gradient-energized concentrative transport of adenosine in renal brush border vesicles , 1984, Pflügers Archiv.

[63]  R. Coulson.  Metabolism and excretion of exogenous adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate. Studies in the isolated perfused rat kidney and in the intact rat. , 1976, The Journal of biological chemistry.

[64]  R. Berne,et al.  Uptake and metabolism of adenosine by human erythrocyte ghosts. , 1972, The American journal of physiology.

[65]  A. Broadus,et al.  Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man. , 1970, The Journal of clinical investigation.

[66]  J. F. Woessner,et al.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. , 1961, Archives of biochemistry and biophysics.

[67]  H. Lee,et al.  Adenosine generation and signaling during acute kidney injury. , 2011, Journal of the American Society of Nephrology : JASN.

[68]  A. McMahon,et al.  Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. , 2010, The American journal of pathology.

[69]  N. Gretz,et al.  Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay. , 2007, Kidney international.

[70]  D. Butlen,et al.  Renal handling of 3′-5′-cyclic AMP in the rat , 2004, Pflügers Archiv.

[71]  S. Nasr,et al.  A1 adenosine receptor activation inhibits inflammation, necrosis, and apoptosis after renal ischemia-reperfusion injury in mice. , 2004, Journal of the American Society of Nephrology : JASN.

[72]  G. Gabbiani,et al.  Interferon-gamma inhibits experimental renal fibrosis. , 1999, Kidney international.

[73]  G. Gurujeyalakshmi,et al.  Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression. , 1995, Experimental lung research.

[74]  F. Holz,et al.  Renovascular effects of adenosine receptor agonists. , 1987, Renal physiology.